Position in TNGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$38,510,223
+$20,457,520 QoQ
Shares Held
1,231,933
+42.8% QoQ
Ownership
0.731%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 247 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 98%
Shared 2%
None 0%
Common Shares in TNGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORTHERN TRUST CORP holds $7,813,568,275 across 424 Biotechnology names. TNGX ranks #44 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,486,478 | $1,235,108,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
916,467 | $571,453,829 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
886,900 | $266,983,504 | |
| 4 | RPRX |
Royalty Pharma plc
|
4,718,859 | $264,586,419 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,117,110 | $209,212,357 | |
| 6 | MRNA |
Moderna, Inc.
|
2,985,329 | $209,062,587 | |
| 7 | INCY |
Incyte Corp
|
1,761,966 | $199,736,460 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,647,345 | $140,337,319 |
All Filings in TNGX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,510,223 | 1,231,933 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $18,052,703 | 862,940 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $7,116,341 | 803,199 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $5,086,711 | 605,561 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $3,074,598 | 600,508 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $615,651 | 449,382 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,585,413 | 513,079 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $3,690,224 | 479,250 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $3,359,721 | 391,576 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $3,184,963 | 401,129 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,082,798 | 412,404 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $4,520,225 | 401,441 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,283,165 | 386,496 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,574,050 | 398,494 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,963,313 | 408,733 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,508,706 | 416,770 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,973,149 | 435,574 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $921,386 | 121,555 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,362,686 | 124,560 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,463,029 | 113,150 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||